|
1
|
Enneking WF: Musculoskeletal tumor
surgery. Churchill Livingstone; New York, NY: 1983
|
|
2
|
Gong L, Liu W, Sun X, Sajdik C, Tian X,
Niu X and Huang X: Histological and clinical characteristics of
malignant giant cell tumor of bone. Virchows Arch. 460:327–334.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feigenberg SJ, Marcus RB Jr, Zlotecki RA,
Scarborough MT and Enneking WF: Whole-lung radiotherapy for giant
cell tumors of bone with pulmonary metastases. Clin Orthop Relat
Res. 1–208. 2002.
|
|
4
|
Ropars M, Kaila R, Cannon SR and Briggs
TW: Primary giant cell tumours of the digital bones of the hand. J
Hand Surg Eur Vol. 32:160–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tian R, Su M, Tian Y, Li F, Li L, Kuang A
and Zeng J: Dual-time point PET/CT with F-18 FDG for the
differentiation of malignant and benign bone lesions. Skeletal
Radiol. 38:451–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lackman RD, Hosalkar HS, Ogilvie CM,
Torbert JT and Fox EJ: Intralesional curettage for grades II and
III giant cell tumors of bone. Clin Orthop Relat Res. 438:123–127.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kivioja AH, Blomqvist C, Hietaniemi K,
Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P and Follerås G:
Cement is recommended in intralesional surgery of giant cell
tumors: A Scandinavian Sarcoma Group study of 294 patients followed
for a median time of 5 years. Acta Orthop. 79:86–93. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H
and Liu W: Giant Cell Tumor of the Extremity: Retrospective
analysis of 621 Chinese patients from one institution. J Bone Joint
Surg Am. 94:461–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moon JC, Kim SR, Chung MJ and Lee YC:
Multiple pulmonary metastases from giant cell tumor of a hand. Am J
Med Sci. 343:171–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Osaka S, Sugita H, Osaka E, Yoshida Y, Ryu
J, Hemmi A and Suzuki K: Clinical and immunohistochemical
characteristics of benign giant cell tumour of bone with pulmonary
metastases: Case series. J Orthop Surg (Hong Kong). 12:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim TS and Park JS: Metastasising
recurrent giant cell tumor: A case report. J Korean Bone Joint
Tumor Soc. 7:73–79. 2001.
|
|
12
|
Mirra JM: Giant cell tumorsBone tumors:
clinical, radiologic and pathologic correlations. Lea and Febiger.
Philadelphia, PA: pp. 941–1020. 1989
|
|
13
|
Averill RM, Smith RJ and Campbell CJ:
Giant cell tumors of the bones of the hand. J Hand Surg Am.
5:39–50. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Balke M, Schremper L, Gebert C, Ahrens H,
Streitbuerger A, Koehler G, Hardes J and Gosheger G: Giant cell
tumor of bone: Treatment and outcome of 214 cases. J Cancer Res
Clin Oncol. 134:969–978. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takeuchi A, Tsuchiya H, Niu X, Ueda T,
Jeon DG, Wang EH, Asavamongkolkul A, Kusuzaki K, Sakayama K and
Kang YK: The prognostic factors of recurrent GCT: A cooperative
study by the Eastern Asian Musculoskeletal oncology group. J Orthop
Sci. 16:196–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muheremu A and Niu X: Pulmonary metastasis
of giant cell tumor of bones. World J Surg Oncol. 12:2612014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jacopin S, Viehweger E, Glard Y, Launay F,
Jouve JL, Bouvier C and Bollini G: Fatal lung metastasis secondary
to index finger giant cell tumor in an 8-year-old child. Orthop
Traumatol Surg Res. 96:310–313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kremen TJ Jr, Bernthal NM, Eckardt MA and
Eckardt JJ: Giant cell tumor of bone: Are we stratifying results
appropriately? Clin Orthop Relat Res. 470:677–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Muheremu A, Huang Z and Niu X: Treatment
for giant cell tumor of the spine metastasizing to the lung: A
report of two cases and a literature review. Oncol Lett.
9:1321–1326. 2015.PubMed/NCBI
|
|
20
|
Werner M: Giant cell tumour of bone:
Morphological, biological and histogenetical aspects. Int Orthop.
30:484–489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anazawa U, Hanaoka H, Shiraishi T, Morioka
H, Morii T and Toyama Y: Similarities between giant cell tumor of
bone, giant cell tumor of tendon sheath, and pigmented villonodular
synovitis concerning ultrastructural cytochemical features of
multinucleated giant cells and mononuclear stromal cells.
Ultrastruct Pathol. 30:151–158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lindeman JH, Hanemaaijer R, Mulder A,
Dijkstra PD, Szuhai K, Bromme D, Verheijen JH and Hogendoorn PC:
Cathepsin K is the principal protease in giant cell tumor of bone.
Am J Pathol. 165:593–600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kotake S, Sato K, Kim KJ, Takahashi N,
Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T and
Kashiwazaki S: Interleukin-6 and soluble interleukin-6 receptors in
the synovial fluids from rheumatoid arthritis patients are
responsible for osteoclast-like cell formation. J Bone Miner Res.
11:88–95. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Collier FM, Huang WH, Holloway WR, Hodge
JM, Gillespie MT, Daniels LL, Zheng MH and Nicholson GC:
Osteoclasts from human giant cell tumors of bone lack estrogen
receptors. Endocrinology. 139:1258–1267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Atkins GJ, Kostakis P, Vincent C, Farrugia
AN, Houchins JP, Findlay DM, Evdokiou A and Zannettino AC: RANK
expression as a cell surface marker of human osteoclast precursors
in peripheral blood, bone marrow, and giant cell tumors of bone. J
Bone Miner Res. 21:1339–1349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balke M, Campanacci L, Gebert C, Picci P,
Gibbons M, Taylor R, Hogendoorn P, Kroep J, Wass J and Athanasou N:
Bisphosphonate treatment of aggressive primary, recurrent and
metastatic giant cell tumour of bone. BMC Cancer. 10:4622010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cowan RW and Singh G: Giant cell tumor of
bone: A basic science perspective. Bone. 52:238–246. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Graziano V and De Laurenzi V: Role of p63
in cancer development. Biochim Biophys Acta. 1816:57–66.
2011.PubMed/NCBI
|
|
29
|
Babeto E, Conceição AL, Valsechi MC,
Junior P Peitl, de Campos Zuccari DA, de Lima LG, Bonilha JL, de
Freitas Calmon M, Cordeiro JA and Rahal P: Differentially expressed
genes in giant cell tumor of bone. Virchows Arch. 458:467–476.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu Y, Maianu L, Melbert BR and Garvey WT:
Facilitative glucose transporter gene expression in human
lymphocytes, monocytes, and macrophages: A role for GLUT isoforms
1, 3, and 5 in the immune response and foam cell formation. Blood
Cells Mol Dis. 32:182–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Malide D, Davies-Hill TM, Levine M and
Simpson IA: Distinct localization of GLUT-1, −3 and −5 in human
monocyte-derived macrophages: Effects of cell activation. Am J
Physiol. 274:E516–E526. 1998.PubMed/NCBI
|
|
32
|
Chung JH, Cho KJ, Lee SS, Baek HJ, Park
JH, Cheon GJ, Choi CW and Lim SM: Overexpression of Glut1 in
lymphoid follicles correlates with false-positive (18)F-FDG PET
results in lung cancer staging. J Nucl Med. 45:999–1003.
2004.PubMed/NCBI
|
|
33
|
Horiuchi C, Tsukuda M, Taguchi T, Ishiguro
Y, Okudera K and Inoue T: Correlation between FDG-PET findings and
GLUT1 expression in salivary gland pleomorphic adenomas. Ann Nucl
Med. 22:693–698. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoshi M, Takada J, Oebisu N, Hata K,
Ieguchi M and Nakamura H: Overexpression of hexokinase-2 in giant
cell tumor of bone is associated with false positive in bone tumor
on FDG-PET/CT. Arch Orthop Trauma Surg. 132:1561–1568. 2012.
View Article : Google Scholar : PubMed/NCBI
|
